Bank of New York Mellon Corp Sells 47,707 Shares of Encompass Health Co. (NYSE:EHC)

Bank of New York Mellon Corp cut its position in Encompass Health Co. (NYSE:EHC) by 3.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,315,320 shares of the company’s stock after selling 47,707 shares during the quarter. Bank of New York Mellon Corp’s holdings in Encompass Health were worth $121,470,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB raised its holdings in Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after purchasing an additional 137 shares in the last quarter. Avior Wealth Management LLC acquired a new position in shares of Encompass Health during the third quarter valued at about $40,000. Tompkins Financial Corp acquired a new position in shares of Encompass Health during the fourth quarter valued at about $46,000. V Square Quantitative Management LLC increased its holdings in shares of Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock valued at $54,000 after acquiring an additional 177 shares in the last quarter. Finally, Morse Asset Management Inc acquired a new position in Encompass Health in the 3rd quarter worth approximately $68,000. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Stock Down 0.2 %

Shares of EHC opened at $100.11 on Friday. Encompass Health Co. has a 52-week low of $73.68 and a 52-week high of $104.55. The company has a market capitalization of $10.09 billion, a PE ratio of 22.45, a price-to-earnings-growth ratio of 2.31 and a beta of 0.90. The stock has a fifty day simple moving average of $96.42 and a two-hundred day simple moving average of $96.36. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. As a group, equities analysts forecast that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 17th. Shareholders of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date is Tuesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is presently 15.25%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. William Blair reiterated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. StockNews.com upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, February 15th. KeyCorp upped their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Monday, February 10th. Royal Bank of Canada restated an “outperform” rating and issued a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. Finally, Barclays upped their price objective on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, February 7th. Ten investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $107.67.

Insiders Place Their Bets

In related news, CAO Andrew L. Price sold 5,042 shares of the firm’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 2.10% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.